Codexis (CDXS) Income from Continuing Operations (2010 - 2026)

Codexis (CDXS) recorded quarterly Income from Continuing Operations of 8704000.0 in Q1 2026, down 190.66% quarter-over-quarter from 9601000.0 in Q4 2025, and up 57.93% on a YoY basis from 5511396.67 in Q1 2025.

Codexis (CDXS) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Codexis' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 8704000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 57.93% year-over-year to 8704000.0; the TTM figure through Mar 2026 stood at 31990000.0 (up 57.04% YoY), while the FY2025 annual figure was 43974000.0, up 32.63% from the prior year.
  • Income from Continuing Operations was 8704000.0 for Q1 2026 at Codexis, down from 9601000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9601000.0 in Q4 2025 to a low of 34908000.0 in Q3 2023.
  • Historically, Income from Continuing Operations has averaged 13399176.47 across 5 years, with a median of 11523000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations slumped 545.28% in 2022, then soared 192.53% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 12604000.0 in 2022, then soared by 42.94% to 7192000.0 in 2023, then sank by 44.27% to 10376000.0 in 2024, then jumped by 192.53% to 9601000.0 in 2025, then plunged by 190.66% to 8704000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 8704000.0 (Q1 2026), 9601000.0 (Q4 2025), and 19615000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -26.94 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -2.97 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -14.46 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -3.40 Mn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1.03 Bn
9 Abivax 94.37 Bn 94.37 Bn - -56.48 Mn
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn -8.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.70 Mn
Dec 31, 2025 9.60 Mn
Sep 30, 2025 -19.62 Mn
Jun 30, 2025 -13.27 Mn
Mar 31, 2025 -20.69 Mn
Dec 31, 2024 -10.38 Mn
Sep 30, 2024 -20.64 Mn
Jun 30, 2024 -22.76 Mn
Mar 31, 2024 -11.51 Mn
Dec 31, 2023 -7.19 Mn
Sep 30, 2023 -34.91 Mn
Jun 30, 2023 -11.52 Mn
Mar 31, 2023 -22.62 Mn
Dec 31, 2022 -12.60 Mn
Sep 30, 2022 -9.99 Mn
Jun 30, 2022 -2.64 Mn
Mar 31, 2022 -8.36 Mn
Dec 31, 2021 -10.19 Mn
Sep 30, 2021 2.24 Mn
Jun 30, 2021 -4.27 Mn